Shares of agribusiness and food company Bunge (BG.N) rise ~1% to $93.48
Morgan Stanley upgrades stock to “overweight” from “equal weight”; raises PT to $120 from $95 New PT represents a ~30% premium to stock’s last close Brokerage says merger with Viterra acts as both a “catalyst and key differentiator for Bunge”, given operational and commercial synergies Expects Bunge’s EPS baseline to move higher on March 10, its Investor Day
MS currently forecasts BG’s mid-cycle EPS baseline at ~$12 versus co’s outlook of $8.50 10 of 12 brokerages rate the stock “buy” or higher, two “hold”; median PT is $110 - LSEG data Including session’s moves, stock up 20% YTD

Morgan Stanley upgrades Bunge to 'overweight' from 'equal weight' and raises the price target to $120 from $95, citing the merger with Viterra as a catalyst. Bunge's shares rise ~1% to $93.48. The new price target represents a ~30% premium to the last close. 10 of 12 brokerages rate the stock 'buy' or higher, with a median price target of $110.

BUZZ-Morgan Stanley upgrades Bunge to 'overweight', raises PT